These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 508547)

  • 1. A study of the disposition of alpha-methyldopa in newborn infants following its administration to the mother for the treatment of hypertension during pregnancy.
    Jones HM; Cummings AJ; Setchell KD; Lawson AM
    Br J Clin Pharmacol; 1979 Nov; 8(5):433-40. PubMed ID: 508547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of conjugation and drug elimination in the human neonate.
    Cummings AJ; Whitelaw AG
    Br J Clin Pharmacol; 1981 Oct; 12(4):511-5. PubMed ID: 6117307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-methyldopa disposition in mothers with hypertension and in their breast-fed infants.
    White WB; Andreoli JW; Cohn RD
    Clin Pharmacol Ther; 1985 Apr; 37(4):387-90. PubMed ID: 3838502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal and neonatal excretion of free and conjugated ritodrine.
    Hayashi E; Kishimoto Y; Tada K; Kudo T; Sekiba K
    Acta Med Okayama; 1992 Dec; 46(6):443-8. PubMed ID: 1485538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal effects of methyldopa therapy in pregnancy hypertension.
    Sulyok E; Bódis J; Hartman G; Ertl T
    Acta Paediatr Hung; 1991; 31(1):53-65. PubMed ID: 1867878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Maternal effects and perinatal safety of labetalol in the treatment of hypertension in pregnancy. Comparison with methyldopa in a randomized cooperative trial].
    Plouin PF; Bréart G; Maillard F; Papiernik E; Relier JP
    Arch Mal Coeur Vaiss; 1987 Jun; 80(6):952-5. PubMed ID: 3116996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disposition of the adrenergic blocker metoprolol in the late-pregnant woman, the amniotic fluid, the cord blood and the neonate.
    Lindeberg S; Sandström B; Lundborg P; Regårdh CG
    Acta Obstet Gynecol Scand Suppl; 1984; 118():61-4. PubMed ID: 6587729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metabolism of 14 C-labelled -methyldopa in normal and hypertensive human subjects.
    Au WY; Dring LG; Grahame-Smith DG; Isaac P; Williams RT
    Biochem J; 1972 Aug; 129(1):1-10. PubMed ID: 4646774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of magnesium and methyldopa for the control of blood pressure in pregnancies complicated with hypertension.
    Rudnicki M; Frølich A; Pilsgaard K; Nyrnberg L; Møller M; Sanchez M; Fischer-Rasmussen W
    Gynecol Obstet Invest; 2000; 49(4):231-5. PubMed ID: 10828704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disposition of the adrenergic blocker metoprolol and its metabolite OH-metoprolol in maternal plasma, amniotic fluid and capillary blood of the neonate.
    Lindeberg S; Lundborg P; Regårdh CG; Sandström B
    Eur J Clin Pharmacol; 1987; 33(4):363-8. PubMed ID: 3443141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative evaluation of metoprolol and methyldopa in the management of pregnancy induced hypertension.
    Oumachigui A; Verghese M; Balachander J
    Indian Heart J; 1992; 44(1):39-41. PubMed ID: 1398694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of no medication versus methyldopa or labetalol in chronic hypertension during pregnancy.
    Sibai BM; Mabie WC; Shamsa F; Villar MA; Anderson GD
    Am J Obstet Gynecol; 1990 Apr; 162(4):960-6; discussion 966-7. PubMed ID: 2183619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-blockers increase the risk of being born small for gestational age or of being institutionalised during infancy.
    Xie RH; Guo Y; Krewski D; Mattison D; Walker MC; Nerenberg K; Wen SW
    BJOG; 2014 Aug; 121(9):1090-6. PubMed ID: 24628701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of acebutolol with methyldopa in hypertensive pregnancy.
    Williams ER; Morrissey JR
    Pharmatherapeutica; 1983; 3(7):487-91. PubMed ID: 6669592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomised comparison of methyldopa and oxprenolol for treatment of hypertension in pregnancy.
    Gallery ED; Saunders DM; Hunyor SN; Györy AZ
    Br Med J; 1979 Jun; 1(6178):1591-4. PubMed ID: 466138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal head circumference and the treatment of maternal hypertension.
    Moar VA; Jefferies MA; Mutch LM; Ounsted MK; Redman CW
    Br J Obstet Gynaecol; 1978 Dec; 85(12):933-7. PubMed ID: 367425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methyldopa versus nifedipine or no medication for treatment of chronic hypertension during pregnancy: A multicenter randomized clinical trial.
    Salama M; Rezk M; Gaber W; Hamza H; Marawan H; Gamal A; Abdallah S
    Pregnancy Hypertens; 2019 Jul; 17():54-58. PubMed ID: 31487657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal effects of maternal administration of acebutolol.
    Dumez Y; Tchobroutsky C; Hornych H; Amiel-Tison C
    Br Med J (Clin Res Ed); 1981 Oct; 283(6299):1077-9. PubMed ID: 6794766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Pilot Study of the Maternal-Fetal Pharmacokinetics of Furosemide in Plasma, Urine, and Amniotic Fluid of Hypertensive Parturient Women Under Cesarean Section.
    Gonçalves PVB; Moreira FL; Benzi JRL; Duarte G; Lanchote VL
    J Clin Pharmacol; 2020 Dec; 60(12):1655-1661. PubMed ID: 32562572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonidine hydrochloride--a safe and effective antihypertensive agent in pregnancy.
    Horvath JS; Phippard A; Korda A; Henderson-Smart DJ; Child A; Tiller DJ
    Obstet Gynecol; 1985 Nov; 66(5):634-8. PubMed ID: 3903581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.